Stories about Chemie

Medison Pharma; Alnylam Pharmaceuticals

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia

Zug, Switzerland (ots/PRNewswire) - - The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one global alliance - Medison, the creator and leader of the multi-regional partnership category, will utilize its unique, unified platform for efficient ...

Nano-Care Deutschland AG

Nano-Care Deutschland AG launches next generation of sustainable PFAS-free oleophobic coatings

Obrist Group

Obrist's concept for a climate-friendly energy industry receives global acclaim

Fraunhofer-Institut für Produktionstechnologie IPT

Hydrogen technologies at the Hannover Messe 2024: Fraunhofer IPT presents system designs for the production of bipolar plates, MEAs and pressure tanks

hubergroup Deutschland GmbH

6

Press Release - More efficient, effective and sustainable - hubergroup Chemicals presents its modern portfolio at the American Coatings Show

Dr. Reddy's Laboratories SA

Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment

Festo SE & Co. KG

You are cordially invited to Festo's press meeting with C. Gerhardt at Analytica

nova-Institut GmbH

5

Advancements in Carbon Capture and Utilisation (CCU) Technology Pave the Way for Novel Applications From Ethylene, to Polymers, Syngas and Even Diamonds

SIBUR

SIBUR attends Geneva roundtable, discusses projects to reduce plastic pollution

GENEVA, SWITZERLAND (ots) - Media OutReach Newswire - Representatives of SIBUR, Russia’s largest producer of polymers and rubbers, attended the Ecumene roundtable in Geneva where they discussed the company’s advanced initiatives in the circular economy and the mitigation of its climate impact. The discussion took place in advance of an upcoming United Nations ...

nova-Institut GmbH

8

Bright Future of Cellulose Fibres in Textiles, Hygiene, Construction and Packaging – Conference Shows Top-Innovation

nova-Institut GmbH

3

From carbon-negative diamonds to CO₂-based fuels for transport – Smart innovations replace fossil-based products

STADA Arzneimittel AG

Press release: STADA continues with double-digit sales and profit growth in 2023

hubergroup Deutschland GmbH

5

Press Release - Performance at the Highest Level: the new NewV set UEL 5000

nova-Institut GmbH

8

Current market study forecasts annual growth of 17 % for bio-based polymers between 2023 and 2028. Demand from Asia and the USA in particular is driving growth, Europe is lagging behind.

LTS Lohmann Therapie-Systeme AG

First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US

nova-Institut GmbH

5

Bio-based innovations for industrial applications: stakeholder event

Lamilux Heinrich Strunz GmbH

LAMILUX Academy webinars enter a new round

nova-Institut GmbH

3

Navigating a Renewable Carbon Future with the Program of the CO₂-Based Fuels and Chemicals Conference 2024

maribus gGmbH

The ocean – a climate champion? How to boost marine carbon dioxide uptake

hubergroup Deutschland GmbH

7

Press Release - hubergroup Chemicals presents its portfolio at PaintIndia

hubergroup Deutschland GmbH

3

Press Release - Management change at the top of the hubergroup

STADA Arzneimittel AG

Press release: STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara

STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara - Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within ...

STADA Arzneimittel AG

Press release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner

Acousia Therapeutics GmbH

Acousia Therapeutics attracts new investor on its path to make hearing loss a treatable disease

Tübingen (ots) - - German pioneer biotech accelerates hearing loss solution development with fresh capital boost Acousia Therapeutics GmbH, a clinical-stage biotech company developing drug candidates against acute and chronic forms of hearing loss, proudly announces Esperante Ventures as the latest addition to its esteemed group of investors. The infusion of fresh ...